The domestic pharmaceutical industry is facing many challenges, as an excellent enterprise model with strong comprehensive strength, listed pharmaceutical companies not only have a great role in promoting the development of the industry.
High-end preparations are improved and innovative on the basis of traditional preparations, with the primary purpose of overcoming therapeutic defects and achieving clinical advantages.
The exhibition area is mainly launched in four topics, respectively, children's drug development strategy and application.
MAH system has stimulated the circulation of approval documents, the conference provides a roadshow and demand release platform.
Compared with ordinary formulations, inhalants have their particularities in dosage form, device and mode of action, high barriers to research and development of inhalation drug delivery, involving multidisciplinary integration.
In order to promote the healthy development of the media industry, the summit focused on the cutting-edge technology.
Society is developing, science and technology is also changing, and the change of science and technology will inevitably bring unexpected "stimulus" to the field of medicine.
Synthetic biology is a subject that rationally designs, transforms and even synthesizes living systems from scratch according to specific goals under the guidance of engineering ideas to solve the problems of human food shortage, energy shortage, environmental pollution, medical health and other aspects.
Antibody drugs are drugs prepared by antibody engineering technology based on cell engineering technology and gene engineering technology.
In 1975, Gilbert and Sanger established DNA sequencing method. 1985 Mullis invented PCR technology.
At present, the development of new drugs in China has gradually moved closer to the direction of original research and innovation in the true sense.
On August 3-4, 2023, the 5th CMC-China China International Biological & Chemical Pharmaceutical Expo in 2023 was held in Suzhou International Expo Center, co-organized by Junda Joint Venture and supported by Shenzhen Huarong.
